The T cell receptor (TCR) is a versatile receptor able to generate different signals that result in distinct T cell responses. The pattern of early signals is determined by the TCR binding kinetics that control the ability of the ligand to coengage TCR and coreceptor. Coengagement of TCR and CD4 results in an agonist signaling pattern with complete tyrosine phosphorylation of TCR subunits, and recruitment and activation of ZAP-70. In contrast, TCR engagement without CD4 coengagement causes a partial agonist type of signaling, characterized by distinct phosphorylation of TCR subunits and recruitment but no activation of ZAP-70. The pathways triggered by partial agonist signaling are unknown. Here, we show that agonists cause association of active lck and active ZAP-70 with p120-GTPase–activating protein (p120-GAP). These associations follow engagement of CD4 or CD3, respectively. In contrast, partial agonists do not activate lck or ZAP-70, but induce association of p120-GAP with inactive ZAP-70. Despite these differences, both agonist and partial agonist signals activate the mitogen-activated protein kinase (MAPK) pathway. However, MAPK activation by partial agonists is transient, supporting a kinetic, CD4-dependent model for the mechanism of action of variant TCR ligands. Transient MAPK activation may explain some of the responses to TCR partial agonists and antagonists.
Skip Nav Destination
Article navigation
18 May 1998
Article|
May 18 1998
Dissociation of Intracellular Signaling Pathways in Response to Partial Agonist Ligands of the T Cell Receptor
Luan A. Chau,
Luan A. Chau
From the *Transplantation and Immunobiology Group, The John P. Robarts Research Institute, and the ‡Departments of Microbiology and Immunology and Medicine, the University of Western Ontario, London, Ontario, Canada N6A 5K8; and the §Committee on Immunology, Ben May Institute for Cancer Research, University of Chicago, Chicago, Illinois 60615
Search for other works by this author on:
Jeffrey A. Bluestone,
Jeffrey A. Bluestone
From the *Transplantation and Immunobiology Group, The John P. Robarts Research Institute, and the ‡Departments of Microbiology and Immunology and Medicine, the University of Western Ontario, London, Ontario, Canada N6A 5K8; and the §Committee on Immunology, Ben May Institute for Cancer Research, University of Chicago, Chicago, Illinois 60615
Search for other works by this author on:
Joaquín Madrenas
Joaquín Madrenas
From the *Transplantation and Immunobiology Group, The John P. Robarts Research Institute, and the ‡Departments of Microbiology and Immunology and Medicine, the University of Western Ontario, London, Ontario, Canada N6A 5K8; and the §Committee on Immunology, Ben May Institute for Cancer Research, University of Chicago, Chicago, Illinois 60615
Search for other works by this author on:
Luan A. Chau
From the *Transplantation and Immunobiology Group, The John P. Robarts Research Institute, and the ‡Departments of Microbiology and Immunology and Medicine, the University of Western Ontario, London, Ontario, Canada N6A 5K8; and the §Committee on Immunology, Ben May Institute for Cancer Research, University of Chicago, Chicago, Illinois 60615
Jeffrey A. Bluestone
From the *Transplantation and Immunobiology Group, The John P. Robarts Research Institute, and the ‡Departments of Microbiology and Immunology and Medicine, the University of Western Ontario, London, Ontario, Canada N6A 5K8; and the §Committee on Immunology, Ben May Institute for Cancer Research, University of Chicago, Chicago, Illinois 60615
Joaquín Madrenas
From the *Transplantation and Immunobiology Group, The John P. Robarts Research Institute, and the ‡Departments of Microbiology and Immunology and Medicine, the University of Western Ontario, London, Ontario, Canada N6A 5K8; and the §Committee on Immunology, Ben May Institute for Cancer Research, University of Chicago, Chicago, Illinois 60615
Address correspondence to J. Madrenas, John P. Robarts Research Institute, Rm. 2-05, PO box 5015, 100 Perth Dr., London, ON, Canada N6A 5K8. Phone: 519-663-5777, Ext. 4242; Fax: 519-663-3789; E-mail: [email protected]
Received:
January 05 1998
Revision Received:
March 03 1998
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1998
J Exp Med (1998) 187 (10): 1699–1709.
Article history
Received:
January 05 1998
Revision Received:
March 03 1998
Citation
Luan A. Chau, Jeffrey A. Bluestone, Joaquín Madrenas; Dissociation of Intracellular Signaling Pathways in Response to Partial Agonist Ligands of the T Cell Receptor . J Exp Med 18 May 1998; 187 (10): 1699–1709. doi: https://doi.org/10.1084/jem.187.10.1699
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement